This combination of subjective physicians’ assessments and validated disease activity indexes appears to reflect a positive trend in clinical SLE management; new composite response indexes which incorporate the physicians’ assessment have recently been developed [ 28 ].
← all excerpts
First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study.
1
—
—